Reducing Binge Eating to Prevent Weight Gain in Black Women
Status: | Recruiting |
---|---|
Conditions: | Obesity Weight Loss, Obesity Weight Loss, Psychiatric |
Therapuetic Areas: | Endocrinology, Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - 70 |
Updated: | 3/2/2019 |
Start Date: | January 12, 2019 |
End Date: | July 2020 |
Contact: | Rachel W. Goode, PhD, MPH |
Email: | rwgoode@email.unc.edu |
Phone: | 919-962-6429 |
Reducing Binge Eating to Prevent Weight Gain in Black Women: A Pilot Study
The purpose of the proposed study is to pilot a 6-month, cognitive-behavioral binge eating
intervention, Appetite Awareness Training (AAT) to reduce binge eating and prevent weight
gain for Black women with a BMI > 25 kg/m² and with weekly binge eating episodes.
Intervention participants will receive a 8-week group AAT intervention, and will also receive
bluetooth-connected scales for daily weighing. Participants will also receive tailored
feedback on self-weighing frequency and weight change. We will follow-up with participants at
six months.
intervention, Appetite Awareness Training (AAT) to reduce binge eating and prevent weight
gain for Black women with a BMI > 25 kg/m² and with weekly binge eating episodes.
Intervention participants will receive a 8-week group AAT intervention, and will also receive
bluetooth-connected scales for daily weighing. Participants will also receive tailored
feedback on self-weighing frequency and weight change. We will follow-up with participants at
six months.
Aim 1. Using an experimental design, examine the feasibility and acceptability of 6-month AAT
(N=40) in North Carolina. Forty overweight and obese (BMI ≥ 25 kg/m²) community-based Black
women will be randomized to the AAT intervention or wait-list control (who will eventually
receive the intervention). AAT participants will meet weekly for 8 weeks, followed by a
4-month period of daily weighing and weekly tailored feedback only. The study will examine
the following: recruitment feasibility, attendance/retention, adherence, satisfaction, and
barriers to completion.
Aim 2: At 2 and 6 months, compare changes in (a) binge eating, eating self-efficacy, and
depressive symptoms and (b) weight, blood pressure, and waist circumference for participants
in the intervention vs. control group.
H_1: Participants in the AAT intervention will report less binge and overeating and gain less
weight than those in the control group at 2 and 6 months.
Secondary aim: Examine characteristics (e.g., baseline BMI, severity of binge eating,
frequency of self-weighing) related to change in binge eating and weight.
(N=40) in North Carolina. Forty overweight and obese (BMI ≥ 25 kg/m²) community-based Black
women will be randomized to the AAT intervention or wait-list control (who will eventually
receive the intervention). AAT participants will meet weekly for 8 weeks, followed by a
4-month period of daily weighing and weekly tailored feedback only. The study will examine
the following: recruitment feasibility, attendance/retention, adherence, satisfaction, and
barriers to completion.
Aim 2: At 2 and 6 months, compare changes in (a) binge eating, eating self-efficacy, and
depressive symptoms and (b) weight, blood pressure, and waist circumference for participants
in the intervention vs. control group.
H_1: Participants in the AAT intervention will report less binge and overeating and gain less
weight than those in the control group at 2 and 6 months.
Secondary aim: Examine characteristics (e.g., baseline BMI, severity of binge eating,
frequency of self-weighing) related to change in binge eating and weight.
Inclusion Criteria:
Individuals are eligible if they are:
- non-Latino Black women,
- over 18 years of age,
- have a BMI ≥ 25kg/m²,
- use a Bluetooth-enabled smartphone,
- report at least one binge eating episode weekly, and
- complete the screening.
Exclusion Criteria:
Individuals will be excluded if they:
- are currently pregnant,
- are in substance abuse treatment,
- are involved in another weight reduction program,
- have a history of anorexia,
- are purging,
- are currently in treatment for eating difficulties,
- are concurrent intravenous drug users or consume >4 alcoholic beverages/day.
We found this trial at
1
site
Kannapolis, North Carolina 28081
Principal Investigator: Rachel W. Goode, PhD, MPH
Phone: 704-250-5062
Click here to add this to my saved trials